DBV TECHNOLOGIES SA-SPON ADR (DBVT) Stock Overview
USA - NASDAQ:DBVT - US23306J2006 - ADR
DBVT Key Statistics, Chart & Performance
The current stock price of DBVT is 15.92 USD. In the past month the price increased by 61.32%. In the past year, price increased by 351.57%.
DBVT Latest News, Press Relases and Analysis
DBVT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.36 | 399.63B | ||
| AMGN | AMGEN INC | 13.63 | 160.07B | ||
| GILD | GILEAD SCIENCES INC | 15.28 | 146.79B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.08 | 104.58B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.64B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.63 | 61.09B | ||
| ARGX | ARGENX SE - ADR | 87.98 | 49.92B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.11 | 34.73B | ||
| INSM | INSMED INC | N/A | 34.57B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.08B | ||
| NTRA | NATERA INC | N/A | 24.63B | ||
| BIIB | BIOGEN INC | 8.97 | 21.06B |
Related stock screener links
About DBVT
Company Profile
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Chatillon, Auvergne-Rhone-Alpes and currently employs 109 full-time employees. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.
Company Info
DBV TECHNOLOGIES SA-SPON ADR
Batiment IRO, 107 Av. de la Republique
Chatillon AUVERGNE-RHONE-ALPES 92120 FR
CEO: Daniel Tasse
Employees: 110
Phone: 33155427878
DBV TECHNOLOGIES SA-SPON ADR / DBVT FAQ
What is the stock price of DBV TECHNOLOGIES SA-SPON ADR today?
The current stock price of DBVT is 15.92 USD. The price increased by 1.73% in the last trading session.
What is the ticker symbol for DBV TECHNOLOGIES SA-SPON ADR stock?
The exchange symbol of DBV TECHNOLOGIES SA-SPON ADR is DBVT and it is listed on the Nasdaq exchange.
On which exchange is DBVT stock listed?
DBVT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for DBV TECHNOLOGIES SA-SPON ADR stock?
8 analysts have analysed DBVT and the average price target is 12.15 USD. This implies a price decrease of -23.7% is expected in the next year compared to the current price of 15.92. Check the DBV TECHNOLOGIES SA-SPON ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DBV TECHNOLOGIES SA-SPON ADR worth?
DBV TECHNOLOGIES SA-SPON ADR (DBVT) has a market capitalization of 435.60M USD. This makes DBVT a Small Cap stock.
How many employees does DBV TECHNOLOGIES SA-SPON ADR have?
DBV TECHNOLOGIES SA-SPON ADR (DBVT) currently has 110 employees.
What are the support and resistance levels for DBV TECHNOLOGIES SA-SPON ADR (DBVT) stock?
DBV TECHNOLOGIES SA-SPON ADR (DBVT) has a support level at 9.45. Check the full technical report for a detailed analysis of DBVT support and resistance levels.
Is DBV TECHNOLOGIES SA-SPON ADR (DBVT) expected to grow?
The Revenue of DBV TECHNOLOGIES SA-SPON ADR (DBVT) is expected to grow by 2930.57% in the next year. Check the estimates tab for more information on the DBVT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DBV TECHNOLOGIES SA-SPON ADR (DBVT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DBVT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DBVT, evaluating the profitability, health, valuation and growth aspects
- DBV TECHNOLOGIES SA-SPON ADR (DBVT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DBV TECHNOLOGIES SA-SPON ADR (DBVT) Sales and EPS estimates to see what analysts future expectations are.
- DBV TECHNOLOGIES SA-SPON ADR (DBVT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DBV TECHNOLOGIES SA-SPON ADR (DBVT) Insider and Institutional Ownership to learn about the owners and their transactions.
- DBV TECHNOLOGIES SA-SPON ADR (DBVT) Stock Chart to make your own analysis
- DBV TECHNOLOGIES SA-SPON ADR (DBVT) Latest news and press-releases to stay up to date.
Does DBV TECHNOLOGIES SA-SPON ADR (DBVT) stock pay dividends?
DBVT does not pay a dividend.
When does DBV TECHNOLOGIES SA-SPON ADR (DBVT) report earnings?
DBV TECHNOLOGIES SA-SPON ADR (DBVT) will report earnings on 2026-03-23, after the market close.
What is the Price/Earnings (PE) ratio of DBV TECHNOLOGIES SA-SPON ADR (DBVT)?
DBV TECHNOLOGIES SA-SPON ADR (DBVT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.89).
What is the Short Interest ratio of DBV TECHNOLOGIES SA-SPON ADR (DBVT) stock?
The outstanding short interest for DBV TECHNOLOGIES SA-SPON ADR (DBVT) is 0.08% of its float. Check the ownership tab for more information on the DBVT short interest.
DBVT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to DBVT. When comparing the yearly performance of all stocks, DBVT is one of the better performing stocks in the market, outperforming 98.33% of all stocks.
DBVT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to DBVT. DBVT may be in some trouble as it scores bad on both profitability and health.
DBVT Financial Highlights
Over the last trailing twelve months DBVT reported a non-GAAP Earnings per Share(EPS) of -4.89. The EPS decreased by -22.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.56% | ||
| ROE | -142.22% | ||
| Debt/Equity | 0.08 |
DBVT Forecast & Estimates
8 analysts have analysed DBVT and the average price target is 12.15 USD. This implies a price decrease of -23.7% is expected in the next year compared to the current price of 15.92.
For the next year, analysts expect an EPS growth of 1.69% and a revenue growth 2930.57% for DBVT